Trabecular meshwork as a new target for the treatment of glaucoma

Drug News and Perspectives

Volumn 19, Issue 3, 2006, Pages 151-158

  Ferrer, Elisa ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 HYDROXY 5 TRIFLUOROMETHYLPHENYL) 5 TRIFLUOROMETHYL 2(3H) BENZIMIDAZOLONE; 1 (5 CHLORO 2 HYDROXYPHENYL) 5 TRIFLUOROMETHYL 2 BENZIMIDAZOLONE; 2 [4 (1 HYDROXYHEXYL)PHENYL] 5 OXOCYCLOPENTANEHEPTANOIC ACID; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIHYPERTENSIVE AGENT; APRACLONIDINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BIMATOPROST; BLEBBISTATIN; BRIMONIDINE; BRINZOLAMIDE; BVT 28949; CANNABINOID RECEPTOR AGONIST; CARBACHOL; CARBONATE DEHYDRATASE INHIBITOR; CHOLINERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; CP 559940; DORZOLAMIDE; ETACRYNIC ACID; LATANOPROST; MEVINOLIN; PILOCARPINE; PROSTAGLANDIN DERIVATIVE; RHO KINASE INHIBITOR; SA 9000; TIMOLOL; UNCLASSIFIED DRUG; UNINDEXED DRUG; Y 39983;

AQUEOUS HUMOR FLOW; ASTHMA; CELL FUNCTION; CHRONIC LUNG DISEASE; CYTOARCHITECTURE; DISEASE EXACERBATION; DRUG EFFECT; GENE TARGETING; GENE TECHNOLOGY; GENE THERAPY; GENE VECTOR; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE ABNORMALITY; OPEN ANGLE GLAUCOMA; OPTIC NERVE DISEASE; REVIEW; TRABECULAR MESHWORK; UNSPECIFIED SIDE EFFECT; VISUAL IMPAIRMENT;

CYTOSKELETAL PROTEINS; EYE PROTEINS; GENE EXPRESSION; GLAUCOMA; GLYCOPROTEINS; HUMANS; TRABECULAR MESHWORK;

EID: 33745060439     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2006.19.3.985929     Document Type: Review

References (73)

1. Weinreb, R.N. and Khaw, P.T. Primary open-angle glaucoma. Lancet 2004, 363: 1711-20.
2. Resnikoff, S. et al. Global data on visual impairment in the year 2002, Bull World Health Organ 2004, 82: 844-51.
3. Coleman, A.L. Glaucoma. Lancet 1999, 354: 1803-10.
4. Khaw, P.T., Shah, P. and Elkington, A.R. Glaucoma-1: Diagnosis. Br Med J 2004, 328: 97-9.
5. Nilsson, S.F.E. and Bill, A. The normal anterior segment. Physiology and neurophysiology of aqueous humor inflow and outflow. In: Glaucoma. P.L. Kaufman and T.W. Mittag (Eds.). London, Mosby-Wolfe 1994.
6. Lütjen-Drecoll, E. and Rohen, J.W. The normal anterior segment. Anatomy of aqueous humor formation and drainage. In: Glaucoma. P.L. Kaufman and T.W. Mittag (Eds.). Mosby-Wolfe, London, 1994.
7. Gabelt, B. and Kaufman, P.L. Aqueous humor hydrodynamics. In: Adler's Physiology of the Eye. 2002.
8. Coroneo, M.T. et al. Electrical and morphological evidence for heterogeneous populations of cultured bovine trabecular meshwork cells. Exp Eye Res 1991, 52: 375-88.
9. Flügel, C., Tamm, E. and Lutjen-Drecoll, E. Different cell populations in bovine trabecular meshwork: An ultrastructural and immunocytochemical study. Exp Eye Res 1991, 52: 681-90.
10. Tamm, E.R. et al. Transforming growth factor-beta 1 induces alpha-smooth muscle-actin expression in cultured human and monkey trabecular meshwork. Exp Eye Res 1996, 62: 389-97.
11. Wiederholt, M. et al. Regulation of outflow rate and resistance in the perfused anterior segment of the bovine eye. Exp Eye Res 1995, 61: 223-34.
12. Mitchell, C.H. et al. Human trabecular meshwork cell volume regulation. Am J Physiol Cell Physiol 2002, 283: C315-26.
13. Soto, D. et al. Modulation of aqueous humor outflow by ionic mechanisms involved in trabecular meshwork cell volume regulation. Invest Ophthalmol Vis Sci 2004, 45: 3650-61.
14. Tian, B. et al. Cytoskeletal involvement in the regulation of aqueous humor outflow. Invest Ophthalmol Vis Sci 2000, 41: 619-23.
15. Lee, D.A. and Higginbotham, E.J. Glaucoma and its treatment: A review. Am J Health Syst Pharm 2005, 62: 691-9.
16. Woodward, D.F. and Gil, D.W. The inflow and outflow of anti-glaucoma drugs. Trends Pharmacol Sci 2004, 25: 238-41.
17. Stamper, R.L., Wigginton, S.A. and Higginbotham, E.J. Primary drug treatment for glaucoma: beta-Blockers versus other medications. Surv Ophthalmol 2002, 47: 63-73.
18. Gabelt, B.T. et al. Aqueous humor dynamics and trabecular meshwork and anterior ciliary muscle morphologic changes with age in rhesus monkeys. Invest Ophthalmol Vis Sci 2003, 44: 2118-25.
19. McLaughlin, C.W. et al. Timolol may inhibit aqueous humor secretion by cAMP-independent action on ciliary epithelial cells. Am J Physiol Cell Physiol 2001, 281: C865-75.
20. Toris, C.B., Camras, C.B. and Yablonski, M.E. Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients. Am J Ophthalmol 1999, 128: 8-14.
21. Hoyng, P.F. and van Beek, L.M. Pharmacological therapy for glaucoma: A review. Drugs 2000, 59: 411-34.
22. Kaufman, P., Wiedman, T. and Robinson, J. Cholinergics, in Pharmacology of the eye: Handbook of experimental pharmacology. S. ML (Ed.). Springer-Verlag, Berlin, 1984.
23. Schachtschabel, U., Lindsey, J.D. and Weinreb, R.N. The mechanism of action of prostaglandins on uveoscleral outflow. Curr Opin Ophthalmol 2000, 11: 112-5.
24. Richter, M. et al. Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamide. Invest Ophthalmol Vis Sci 2003, 44: 4419-26.
25. Gasull, X. et al. Cell membrane stretch modulates the high-conductance Ca2+-activated K+ channel in bovine trabecular meshwork cells. Invest Ophthalmol Vis Sci 2003, 44: 706-14.
26. Llobet, A. et al. Identification of Kir2.1 channel activity in cultured trabecular meshwork cells. Invest Ophthalmol Vis Sci 2001, 42: 2371-9.
27. Stumpff, F. et al. Characterization of maxi-K-channels in bovine trabecular meshwork and their activation by cyclic guanosine monophosphate. Invest Ophthalmol Vis Sci 1997, 38: 1883-92.
28. Srinivas, S.P. et al. Cell volume response to hyposmotic shock and elevated cAMP in bovine trabecular meshwork cells. Exp Eye Res 2004, 78: 15-26.
29. Wiederholt, M. Thieme, H. and Stumpff, F. The regulation of trabecular meshwork and ciliary muscle contractility. Prog Retin Eye Res 2000, 19: 271-95.
30. Gribkoff, V.K. Starrett, J.E., Jr. and Dworetzky, S.I. Maxi-K potassium channels: Form, function, and modulation of a class of endogenous regulators of intracellular calcium. Neuroscientist 2001, 7: 166-77.
31. Stumpff, F. et al. Stimulation of cannabinoid (CB1) and prostanoid (EP2) receptors opens BKCa channels and relaxes ocular trabecular meshwork. Exp Eye Res 2005, 80: 697-708.
32. Wiederholt, M. and Stumpff, F. The trabecular meshwork and aqueous humor reabsorption. In: The Eye's Aqueous Humor. From Secretion to Glaucoma. M.M. Civan, (Ed). Academic Press, New York, 1998, 163-201.
33. Gual, A. et al. Effects of time of storage, albumin, and osmolality changes on outflow facility (C) of bovine anterior segment in vitro. Invest Ophthalmol Vis Sci 1997, 38: 2165-71.
34. Erickson, K.A., Schroeder, A. and Netland, P.A. Verapamil increases outflow facility in the human eye. Exp Eye Res 1995, 61: 565-7.
35. Thieme, H. et al. Effects of unoprostone and endothelin 1 on L-type channel currents in human trabecular meshwork cells. Ophthalmic Res 2005, 37: 293-300.
36. Lutjen-Drecoll, E. Functional morphology of the trabecular meshwork in primate eyes. Prog Retin Eye Res 1999, 18: 91-119.
37. Tumminia, S.J. et al. Mechanical stretch alters the actin cytoskeletal network and signal transduction in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 1998. 39: 1361-71.
38. Shimazaki, A. et al. New ethacrynic acid derivatives as potent cytoskeletal modulators in trabecular meshwork cells. Biol Pharm Bull 2004, 27: 846-50.
39. Tian, B. and Kaufman, P.L. Effects of the Rho kinase inhibitor Y-27632 and the phosphatase inhibitor calyculin A on outflow facility in monkeys. Exp Eye Res 2005, 80: 215-25.
40. Nakajima, E. et al. Contribution of ROCK in contraction of trabecular meshwork: Proposed mechanism for regulating aqueous outflow in monkey and human eyes. J Pharm Sci 2005, 94: 701-8.
41. Zhang, M. and Rao, P.V. Blebbistatin, a novel inhibitor of myosin II ATPase activity, increases aqueous humor outflow facility in perfused enucleated porcine eyes. Invest Ophthalmol Vis Sci 2005, 46: 4130-8.
42. Song, J. et al. Effects of cholesterol-lowering statins on the aqueous humor outflow pathway. Invest Ophthalmol Vis Sci 2005, 46: 2424-32.
43. Pintor, J. Pelaez, T. and Peral, A. Adenosine tetraphosphate, Ap4, a physiological regulator of intraocular pressure in normotensive rabbit eyes. J Pharmacol Exp Ther 2004, 308: 468-73.
44. Pintor, J. et al. Presence of diadenosine polyphosphates in the aqueous humor: Their effect on intraocular pressure. J Pharmacol Exp Ther 2003, 304: 342-8.
45. Soto, D. et al. Effects of dinucleaside polyphosphates on trabecular meshwork cells and aqueous humor outflow facility. J Pharmacol Exp Ther 2005, 314: 1042-51.
46. Crosson, C.E. Intraocular pressure responses to the adenosine agonist cyclohexyladenosine: Evidence for a dual mechanism of action. Invest Ophthalmol Vis Sci 2001, 42: 1837-40.
47. Sharif, N.A. et al. Human ciliary muscle and trabecular meshwork cells express functional serotonin-2 (5-HT2) receptors coupled to phosphoinositide turnover and [Ca2+]i mobilization. Invest Ophthalmol Vis Sci 2003, 44: E-Abst 2084.
48. Bunch, T.J. et al. BVT.28949 as a potential ocular hypotensive agent in monkeys. Invest Ophthalmol Vis Sci 2004, 45: E-Abst 5040.
49. Camelo, S. Kezic, J. and McMenamin, P.G. Anterior chamber-associated immune deviation: A review of the anatomical evidence for the afferent arm of this unusual experimental model of ocular immune responses. Clin Experiment Ophthalmol 2005, 33: 426-32.
50. Stone, E.M. et al. Identification of a gene that causes primary open angle glaucoma. Science 1997, 275: 668-70.
51. Tamm, E.R. et al. Modulation of myocilin/TIGR expression in human trabecular meshwork. Invest Ophthalmol Vis Sci 1999, 40: 2577-82.
52. Stoilov, I. Akarsu, A.N. and Sarfarazi, M. Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21. Hum Mol Genet 1997, 6: 641-7.
53. Rezaie, T. et al. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 2002, 295: 1077-9.
54. Gonzalez, P., Epstein, D.L. and Borras, T. Genes upregulated in the human trabecular meshwork in response to elevated intraocular pressure. Invest Ophthalmol Vis Sci 2000, 41: 352-61.
55. Vittal, V. et al. Changes in gene expression by trabecular meshwork cells in response to mechanical stretching. Invest Ophthalmol Vis Sci 2005, 46: 2857-68.
56. Borras, T. et al. Effects of elevated intraocular pressure on outflow facility and TIGR/MYOC expression in perfused human anterior segments. Invest Ophthalmol Vis Sci 2002, 43: 33-40.
57. Vittitow, J. and Borras, T. Genes expressed in the human trabecular meshwork during pressure-induced homeostatic response. J Cell Physiol 2004, 201: 126-37.
58. Vittitow, J. and Borras, T. Expression of optineurin, a glaucoma-linked gene, is influenced by elevated intraocular pressure. Biochem Biophys Res Commun 2002, 298: 67-74.
59. Wang, N. et al. Activation of a tissue-specific stress response in the agueous outflow pathway of the eye defines the glaucoma disease phenotype. Nat Med 2001, 7: 304-9.
60. Shishodia, S. and Aggarwal, B.B. Nuclear factor-kappaB activation: A question of life or death. J Biochem Mol Biol 2002, 35: 28-40.
61. Gardlik, R. et al. Vectors and delivery systems in gene therapy. Med Sci Monit 2005, 11: RA110-21.
62. Borras, T. et al. Non-invasive observation of repeated adenoviral GFP gene delivery to the anterior segment of the monkey eye in vivo. J Gene Med 2001, 3: 437-49.
63. Challa, P. et al. Lentiviral mediated gene delivery to the anterior chamber of rodent eyes. Mol Vis 2005, 11: 425-30.
64. Borras, T. et al. Gene therapy for glaucoma: Treating a multifaceted, chronic disease. Invest Ophthalmol Vis Sci 2002, 43: 2513-8.
65. Kee, C., Sohn, S. and Hwang, J.M. Stromelysin gene transfer into cultured human trabecular cells and rat trabecular meshwork in vivo. Invest Ophthalmol Vis Sci 2001, 42: 2856-60.
66. Loewen, N. et al. Genetic modification of human trabecular meshwork with lentiviral vectors. Hum Gene Ther 2001, 12: 2109-19.
67. Borras, T. et al. Adenoviral reporter gene transfer to the human trabecular meshwork does not alter aqueous humor outflow. Relevance for potential gene therapy of glaucoma. Gene Ther 1999, 6: 515-24.
68. Loewen, N. et al. Long-term, targeted genetic modification of the aqueous humor outflow tract coupled with noninvasive imaging of gene expression in vivo. Invest Ophthalmol Vis Sci 2004, 45: 3091-8.
69. Stamer, W.D. et al. Expression of aquaporin-1 in human trabecular meshwork cells: Role in resting cell volume. Invest Ophthalmol Vis Sci 2001, 42: 1803-11.
70. Bradley, J.M. et al. Effect of matrix metalloproteinases activity on outflow in perfused human organ culture. Invest Ophthalmol Vis Sci 1998, 39: 2649-58.
71. Vittitow, J.L. et al. Gene transfer of dominant-negative RhoA increases outflow facility in perfused human anterior segment cultures. Mol Vis 2002, 8: 32-44.
72. Rao, P.V. et al. Expression of dominant negative Rho-binding domain of Rho-kinase in organ cultured human eye anterior segments increases aqueous humor outflow. Mol Vis 2005, 11: 288-97.
73. Gomez-Cabrero, A. et al. Use of transduction proteins to target trabecular meshwork cells: Outflow modulation by profilin 1. Mol Vis 2005, 11: 1071-82.